GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Citius Oncology Inc (NAS:CTOR) » Definitions » Other Gross PPE

CTOR (Citius Oncology) Other Gross PPE : $0.00 Mil (As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Citius Oncology Other Gross PPE?

Citius Oncology's Other Gross PPE for the quarter that ended in Sep. 2024 was $0.00 Mil.


Citius Oncology Other Gross PPE Historical Data

The historical data trend for Citius Oncology's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Citius Oncology Other Gross PPE Chart

Citius Oncology Annual Data
Trend Sep22 Sep23 Sep24
Other Gross PPE
- - -

Citius Oncology Semi-Annual Data
Sep22 Sep23 Sep24
Other Gross PPE - - -

Citius Oncology Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


Citius Oncology Business Description

Traded in Other Exchanges
N/A
Address
11 Commerce Drive, First Floor, Cranford, NY, USA, 07016
Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.